IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
1-Year Return
17.25%
This Quarter Return
+9.77%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$210M
AUM Growth
-$50M
(-19%)
Cap. Flow
-$6.83M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
49.98%
Holding
57
New
3
Increased
11
Reduced
5
Closed
6
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.21M |
| 2 |
CELG
Celgene Corp
CELG
|
$4.39M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$4.18M |
| 4 |
Incyte
INCY
|
$3.92M |
| 5 |
Exelixis
EXEL
|
$3.53M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$12.1M |
| 2 |
Biogen
BIIB
|
$10.5M |
| 3 |
ASXC
Asensus Surgical, Inc.
ASXC
|
$3.82M |
| 4 |
Verastem
VSTM
|
$3.44M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$2.97M |
Sector Composition
| 1 | Healthcare | 92.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RSLS
51
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
| $2K | ﹤0.01% |
375
| – | – |
|
|
52
Biogen
BIIB
$20.4B
| – | – |
-36,208
| Closed | -$10.5M |
|
53
Rigel Pharmaceuticals
RIGL
$702M
| – | – |
-37,000
| Closed | -$1.04M |
|
54
Viking Therapeutics
VKTX
$2.96B
| – | – |
-70,000
| Closed | -$664K |
|
|
55
Verastem
VSTM
$601M
| – | – |
-41,667
| Closed | -$3.44M |
|
|
ASXC
56
DELISTED
Asensus Surgical, Inc.
ASXC
| – | – |
-68,391
| Closed | -$3.82M |
|
|
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-24,000
| Closed | -$906K |
|